1 Min Read
March 31 (Reuters) - Casi Pharmaceuticals Inc
* CASI Pharmaceuticals reports 2016 fourth quarter and full year financial results
* Q4 loss per share $0.05 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.